CPC A61B 5/0263 (2013.01) [A61B 5/0044 (2013.01); A61B 5/4848 (2013.01); A61B 5/7275 (2013.01); G16H 20/10 (2018.01); G16H 50/30 (2018.01); A61K 49/06 (2013.01); G16H 30/40 (2018.01); Y02A 90/10 (2018.01)] | 18 Claims |
1. A method for treating a subject with myocardial infarction, comprising:
administering to the subject an effective amount of a composition comprising a chelating agent, at least in chronic phase of the myocardial infarction, based on knowledge of an increase in iron oxide deposition in the chronic phase in the infarcted region relative to a remote region following reperfusion hemorrhage,
wherein the subject has undergone reperfusion following the myocardial infarction, the subject has hemorrhage in the myocardial infarct, and
the subject has been detected to have an increase in iron oxide deposition in a hemorrhagic infarcted region of the subject's heart relative to the remote region of the subject's heart.
|